Injection of a new long-acting insulin combined with another drug improves glucose control in patients with type 2 diabetes and, additionally, is associated with weight loss, a multinational clinical trial has found.
Injection of a new long-acting insulin combined with another drug improves glucose control in patients with type 2 diabetes and, additionally, is associated with weight loss, a multinational clinical trial has found.